Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
55-80 years old
Post-menopausal female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights
Study Summary
This trial will look at how exercise at different times of day affects blood pressure & other measures of blood vessel health in older women with hypertension.
Who is the study for?
This trial is for postmenopausal females aged 55-80 with high blood pressure, who are not on medication or have controlled blood pressure with medication. Participants should be able to walk without help and not be very active already. They can't join if they smoke, work night shifts, or have certain diseases like diabetes, heart failure, or recent cancer.Check my eligibility
What is being tested?
The study looks at how exercising in the morning versus early evening affects blood pressure and vascular health in older women with hypertension. It explores whether timing exercise routines can improve treatment outcomes similar to taking medications at specific times of day.See study design
What are the potential side effects?
Since this trial involves exercise as an intervention rather than medication, side effects may include typical responses to physical activity such as muscle soreness, fatigue, and increased heart rate during exercise.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 55 and 80 years old.
Select...
I am a woman who has gone through menopause.
Select...
I can walk on my own without help.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Nocturnal systolic blood pressure (BP)
Secondary outcome measures
Hypotension
Endothelial function
Microvascular function
Other outcome measures
Blood Pressure Monitoring, Ambulatory
Trial Design
2Treatment groups
Experimental Treatment
Group I: Morning (AM)Experimental Treatment2 Interventions
Before 10 A.M.
Group II: Evening (PM)Experimental Treatment2 Interventions
After 4 P.M.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~760
Control
2011
Completed Phase 4
~15780
Find a Location
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,837 Previous Clinical Trials
47,851,580 Total Patients Enrolled
Michigan State UniversityLead Sponsor
185 Previous Clinical Trials
601,931 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently smoking or vaping.You work during the evening.I have a heart or blood vessel condition, like diabetes or heart failure.You have a very high body mass index, which means you are extremely overweight.Your blood pressure is too high, even with medication.You are a morning or early evening person.I am between 55 and 80 years old.I am a woman who has gone through menopause.I can walk on my own without help.You regularly do at least 150 minutes of moderate exercise or 75 minutes of intense exercise per week.I have a chronic lung condition like COPD or pulmonary hypertension.I was diagnosed with cancer within the last 5 years.
Research Study Groups:
This trial has the following groups:- Group 1: Morning (AM)
- Group 2: Evening (PM)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there currently any vacant slots available in this research project?
"According to clinicaltrials.gov, the trial is no longer actively recruiting patients after its initial posting on November 15th 2022 and subsequent update on October 25th 2022. Nonetheless, there are currently 746 other medical studies that have begun enlisting participants."
Answered by AI
Is eligibility for this experiment restricted to those of a certain age range?
"This research is enrolling persons aged between 55 and 80 years old."
Answered by AI
Who are the appropriate candidates for this clinical experiment?
"47 hypertensive individuals aged between 55 and 80 are the target of this clinical trial. To be considered for inclusion, participants must meet certain criteria: elderly (55-80 years old), elevated systolic BP (130mmHg+) and diastolic BP (≥80 mmHg), independent ambulatory ability, postmenopausal female status, early or intermediate chronotype."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger